A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinib

Second-generation tyrosine kinase inhibitors (TKI2) often induce molecular remission, and prolonged survival with a better tolerance in imatinib-resistant chronic myelogenous leukaemia (CML) patients. We report the case of a CML in first chronic phase who was diagnosed in August 2003 in a young 24 y...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Martino, Suella, Daguindau, Etienne, Ferrand, Christophe, Bamoulid, Jamal, Hayette, Sandrine, Nicolini, F-E, Capellier, G., Deconinck, Eric, Larosa, Fabrice
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3850373/
https://ncbi.nlm.nih.gov/pubmed/24371772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2013.02.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars